NEKTAR THERAPEUTICS — Director's Dealing 2010

Sep 17, 2010

SEC Form 4/A — Form 4/A

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2010-09-14

Reporting Person: KUEBLER CHRISTOPHER A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-09-14	Stock Option	$14.26	A	30000	Acquired	2018-09-14	Common Stock (30000)	Direct

Footnotes

F1: The Reporting Person is receiving this equity compensation under the Amended and Restated Compensation Plan for Non-Employee Directors.

F2: 1/12th of the shares subject to the stock option shall vest per calendar month following September 30, 2010 (with all of such shares subject to the stock option becoming vested at September 30, 2011), provided that the Reporting Person continues his or her service as a director.